Suzhou MedicalSystem Technology Co., Ltd. (SHA:603990)
China · Delayed Price · Currency is CNY 15.18
+0.01 (0.07%)
Apr 16, 2026, 3:00 PM CST
SHA:603990 Revenue
In the year 2025, Suzhou MedicalSystem Technology had annual revenue of 301.48M CNY, down -35.04%. Suzhou MedicalSystem Technology had revenue of 78.57M in the quarter ending December 31, 2025, a decrease of -24.29%.
Revenue
301.48M
Revenue Growth
-35.04%
P/S Ratio
15.18
Revenue / Employee
477.02K
Employees
632
Market Cap
4.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 301.48M | -162.59M | -35.04% |
| Dec 31, 2024 | 464.07M | -154.07M | -24.93% |
| Dec 31, 2023 | 618.14M | 312.63M | 102.33% |
| Dec 31, 2022 | 305.51M | -48.34M | -13.66% |
| Dec 31, 2021 | 353.85M | 45.77M | 14.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.42B |
| Shenzhen Mindray Bio-Medical Electronics | 33.28B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 31.63B |
| Sichuan Biokin Pharmaceutical | 2.52B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Hunan Fangsheng Pharmaceutical | 1.68B |
| Hefei Lifeon Pharmaceutical | 1.47B |
| SMO ClinPlus CO.,LTD. | 819.09M |